$1.16
-0.0138[-1.18%]
At close: May 10
$1.16
0[0.00%]
After Hours: 6:09PM EDT
NeuroSense Therapeutics
(NASDAQ:NRSN)NeuroSense Therapeutics Stock (NASDAQ:NRSN), Earnings Estimates, EPS, and Revenue
NeuroSense Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 30
EPS Estimate
$-0.190
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of NeuroSense Therapeutics using advanced sorting and filters.
No data available to display
ticker | Company Name | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Date | Get Alert |
|---|
FAQ
When is NeuroSense Therapeutics (NASDAQ:NRSN) reporting earnings?
NeuroSense Therapeutics (NRSN) is scheduled to report earnings on May 30, 2024. The last reported earnings were for reported on April 5, 2024 for Q4.
What were the latest earnings per share (EPS) for NeuroSense Therapeutics (NASDAQ:NRSN)?
The Actual EPS was $-0.16, which beat the estimate of $-0.23.
What were NeuroSense Therapeutics’s (NASDAQ:NRSN) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.